
About DiaMonTech
DiaMonTech is a Healthcare company based in Berlin (Germany) founded in 2015 by Werner MΓ€ntele, Werner Mantele, Christian Mantele, Rainer Gith, and Thorsten Lubinski. It operates as a non-invasive blood glucose monitoring technology is developed using lasers. DiaMonTech has raised $19.24 million across 6 funding rounds from investors including Disrupt Technology Venture, Samsung Venture Investment and Moll Family. The company has 20 employees. Its chief executive is Thorsten Lubinski. DiaMonTech offers products and services including D-Pocket, Diamoki, and D-Sensor. Its focus areas include Life Sciences, Diabetes, Medical Devices and Monitoring Devices. Its legal entity is DiaMonTech AG. Its competitors include Dexcom, Livongo, One Drop, Bigfoot Biomedical and mySugr and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
Developer of non-invasive blood glucose monitoring technology. This technology utilizes a novel laser-based method to measure glucose levels in interstitial fluid, eliminating the need for needles or test strips. The company is developing a handheld device for consumer use and a miniaturized sensor for integration into other devices. The technology is currently undergoing clinical trials and regulatory processes before market launch. A companion app is also under development to track glucose levels, along with other health data.
- Headquarters Berlin, Germany
- Employees 20
- Founders Werner Mäntele, Werner Mantele, Christian Mantele, Rainer Gith, Thorsten Lubinski
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website diamontech.de
- Social LinkedIn
- Legal Name Diamontech Ag
- Total Equity Funding$19.24M (USD)
in 6 rounds
- InvestorsDisrupt Technology Venture
& 8 more
- Employee Count20
Products & Services of DiaMonTech
DiaMonTech offers a comprehensive portfolio of products and services, including D-Pocket, Diamoki, and D-Sensor.
Handheld tool for non-invasive blood glucose measurement.
App for tracking blood sugar and other health metrics.
Miniaturized sensor for wearable device integration.
Funding Insights of DiaMonTech
DiaMonTech has successfully raised a total of $19.24M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.24M
- Total Rounds 6
- Investors Count 9
All 6 funding rounds of DiaMonTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | – | Series A | β | Disrupt Technology Venture | β |
| Dec 2023 | – | Series A | β | Moll Family | β |
| Feb 2022 | $5.68M | Series A | β | Unorthodox Ventures, Samsung Venture Investment | |
| Sep 2019 | $7.72M | Series A | β | Yuanbio Venture Capital | |
| Sep 2018 | $5.84M | Series A | β | Macnica, Jindong Capital | β |
| Jun 2018 | – | Seed | β | IBB Ventures | β |
9 investors in total: 9 institutional.
Investors in DiaMonTech
DiaMonTech has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Disrupt Technology Venture, Samsung Venture Investment and Moll Family.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments and acceleration services are provided to early-stage healthtech startups. | 2012 | disruptignite.com | Bangkok, Thailand | |
Early-stage investments are made in medical and construction technology. | – | unorthodoxventures.com | Austin, United States | |
Venture capital investments are made in promising startups. | 1999 | samsungventure.co.kr | Seocho, South Korea | |
Venture capital firm focused on multiple sectors | – | ibbventures.de | Berlin, Germany | |
BioVenture is focused on early and growth-stage healthcare investments. | 2013 | bioventure.com.cn | Suzhou, China | |
- | – | jindongcapital.com | - | |
- | – | mollfamily.tcc.mode | - | |
- | – | g-l.berlin | - | |
- | – | macnica.co.jp | - |
Investor details for DiaMonTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DiaMonTech
7 people are tracked at DiaMonTech (7 in leadership); the tracked headcount is 20.
| Name | Role | Group |
|---|---|---|
Werner Mäntele | Co-Founder & Head Of Research And Development | Leadership |
Werner Mantele | Co-Founder | Leadership |
Christian Mantele | Co-Founder | Leadership |
Rainer Gith | Co-Founder | Leadership |
Thorsten Lubinski | Co-Founder & CEO | Leadership |
Catalina Plesmann | Head of Marketing | Leadership |
Berend Meyer | Head of Finance | Leadership |
Complete people profiles for DiaMonTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DiaMonTech
3 dated milestones of DiaMonTech across 9 years, from founding to its latest funding, stage changes and deals.
- Founded DiaMonTech is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
Competitors of DiaMonTech
DiaMonTech has 10 listed competitors in our database, 10 of them funded. They include Dexcom, Livongo, One Drop, Bigfoot Biomedical and mySugr, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions | |
| bigfootbiomedical.com | 2014 | Milpitas, United States | $214.51M | 133 | Developer of a closed-loop automated insulin delivery system | |
| mysugr.com | 2012 | Vienna, Austria | $4.8M | – | Gamified apps for diabetes management and therapy are provided. | |
| janacare.com | 2011 | Newton, United States | $26.59M | – | Mobile-based diagnostics for diabetes prevention and management are provided. | |
| caura.com | 2016 | London, United Kingdom | $4.2M | 11 | Auto insurance and vehicle services are provided via mobile app. | |
| sano.co | 2011 | San Francisco, United States | $24.13M | – | Provider of blood sugar monitoring wearable device | |
| telcare.com | 2008 | Bethesda, United States | $66.69M | 21 | Diabetes is managed via cellular technology and social networking. | |
| levels.com | 2019 | United States | $67M | 35 | Wearable devices for metabolic health insights are provided. |
Detailed competitors of DiaMonTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DiaMonTech
The website of DiaMonTech (diamontech.de) receives about 8.3K visits a month.
- Monthly visits8.3K
▲ 20.3% vs previous month
Websites whose visitors overlap most with DiaMonTech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
diabetes-deutschland.de | diabetes-deutschland.de | 100% | – | #1,361,320 | β |
freestylelibre.de | freestylelibre.de | 92% | – | #94,313 | β |
diabinfo.de | diabinfo.de | 87% | – | #284,243 | β |
diabetes.help | diabetes.help | 83% | – | – | β |
diabetes-news.de | diabetes-news.de | 75% | – | #736,158 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 16 similar websites and full traffic analytics for DiaMonTech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diabetes
10 companies that operate in the same segment as DiaMonTech (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 237 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 253 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diamontech
Complete news archive for DiaMonTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DiaMonTech
DiaMonTech was founded in 2015 and raised its 1st funding round 3 years after it was founded.
DiaMonTech is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Thorsten Lubinski is the current CEO of DiaMonTech. They have also founded this company.
DiaMonTech is a funded company, having raised a total of $19.24M across 6 funding rounds to date.
DiaMonTech has 20 employees.
Developer of non-invasive blood glucose monitoring technology. This technology utilizes a novel laser-based method to measure glucose levels in interstitial fluid, eliminating the need for needles or test strips. The company is developing a handheld device for consumer use and a miniaturized sensor for integration into other devices. The technology is currently undergoing clinical trials and regulatory processes before market launch. A companion app is also under development to track glucose levels, along with other health data.
DiaMonTech's top competitors include Dexcom, Bigfoot Biomedical and One Drop.
DiaMonTech offers D-Pocket, Diamoki, and D-Sensor.
DiaMonTech has 9 investors. Key investors include Disrupt Technology Venture, Samsung Venture Investment, Moll Family, Unorthodox Ventures, and IBB Ventures.
DiaMonTech operates through Diamontech Ag.
